<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; 로얄 소사이어티</title>
	<atom:link href="http://www.chsc.or.kr/tag/%EB%A1%9C%EC%96%84%20%EC%86%8C%EC%82%AC%EC%9D%B4%EC%96%B4%ED%8B%B0/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[구제역] 2001년 영국 구제역, 로얄 소사이어티 보고서</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=2502</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=2502#comments</comments>
		<pubDate>Tue, 04 Jan 2011 12:40:51 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[2001]]></category>
		<category><![CDATA[FMD]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[livestock]]></category>
		<category><![CDATA[구제역]]></category>
		<category><![CDATA[로얄 소사이어티]]></category>
		<category><![CDATA[영국]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=2502</guid>
		<description><![CDATA[2001년 영국의 구제역 발생 및 전파, 그리고 방역대책을 다룬 로얄 소사이어티의2002년 보고서 전문Infectious diseases in livestockScientific questions relating to the transmission,prevention and control of epidemic outbreaks ofinfectious disease [...]]]></description>
				<content:encoded><![CDATA[<p>2001년 영국의 구제역 발생 및 전파, 그리고 방역대책을 다룬 로얄 소사이어티의<BR>2002년 보고서 전문<BR><BR>Infectious diseases in livestock<BR><BR>Scientific questions relating to the transmission,<BR>prevention and control of epidemic outbreaks of<BR>infectious disease in livestock in Great Britain<BR><BR>Contents<BR><BR>Summary and main recommendations vii<BR>1 Overview 1<BR>(a) Introduction 1<BR>(b) Origins of this inquiry 2<BR>(c) The public background and the possibilities 4<BR>(d) The issues of ‘disease-free’ status 5<BR>References 7<BR>2 The modern livestock industry 9<BR>(a) General situation 9<BR>(b) Cattle 11<BR>(c) Sheep 12<BR>(d) Pigs 12<BR>(e) Poultry (excluding eggs) 13<BR>(f) Horses 14<BR>(g) Fish farming 14<BR>(h) Exports 15<BR>References 16<BR>3 Infectious diseases of livestock 17<BR>(a) List A and List B diseases and definitions 17<BR>(i) Foot-and-mouth disease 18<BR>(ii) Classical swine fever (CSF) 26<BR>(iii) African swine fever (ASF) 27<BR>(iv) Avian influenza (AI) 27<BR>(v) Newcastle disease 28<BR>(vi) Blue tongue (BT) and African horse sickness (AHS) 29<BR>(b) Diseases affecting the main livestock sectors 30<BR>(i) Cattle 30<BR>(ii) Sheep 31<BR>(iii) Pigs 32<BR>(iv) Poultry 33<BR>(v) Horses 33<BR>(vi) Fish farming 35<BR>(c) Conclusion and recommendations 35<BR>References 36<BR>4 The trading dimension 39<BR>(a) The world trading framework and the role of the OIE and its reference laboratories 39<BR>(b) Trading and ‘disease-free status’ 40<BR>(c) Trading within the EU 40<BR>5 Surveillance, biosecurity and livestock management 43<BR>(a) Introduction 43<BR>(b) The global threat 43<BR>(i) FMD 44<BR>(ii) Bluetongue virus 45<BR>(c) International surveillance 45<BR>(d) Imports: the rules for trade 46<BR>(e) Imports: policing the frontiers 48<BR>(f) National surveillance 49<BR>(i) Responding to early warnings 49<BR>(ii) Reducing animal movements 49<BR>(iii) Surveillance on the farm: the farmer–veterinarian linkage 51<BR>(iv) Reducing risk on the farm: biosecurity and livestock management practices 52<BR>(g) Recommendations 54<BR>References 55<BR>6 Epidemiology, data and modelling 57<BR>(a) Introduction 57<BR>(b) Why are some outbreaks difficult to control? 58<BR>(i) How do outbreaks grow and then decline? 58<BR>(ii) The problem of early infectivity 59<BR>(iii) The benefits of decisive interventions 61<BR>(c) Management and analysis of the data 62<BR>(i) What can analyses offer? 62<BR>(ii) Data quality and data management 63<BR>(d) Data requirements 64<BR>(i) Case finding and contact tracing 64<BR>(ii) Livestock demography and farm geography 64<BR>(iii) Epidemiology of transmission 65<BR>(iv) Control options, and their likely impact and logistical requirements 65<BR>(e) Mathematical modelling 66<BR>(i) Types of model 66<BR>(ii) Developing and testing models 70<BR>(iii) Use of models before the next outbreak 70<BR>(iv) Use of models during an outbreak 70<BR>(f) Future requirements 71<BR>References 73<BR>7 Diagnosis 75<BR>(a) Introduction 75<BR>(b) The general principles 75<BR>(c) The specific diagnosis of foot-and-mouth disease (FMD) 77<BR>(i) Clinical diagnosis in the field 78<BR>(ii) Laboratory diagnosis of the index case 78<BR>(iii) Diagnosis during an outbreak 79<BR>(iv) Surveillance after an outbreak 79<BR>(d) Improved diagnostics and their potential application to the decentralisation of diagnosis 79<BR>(i) The need for speed 79<BR>(ii) PCR methods for the detection of nucleic acid 80<BR>(iii) Detection of viral antigen and antibody by ELISA 81<BR>(e) The prospect of novel approaches applied to diagnosis and disease control 81<BR>(i) Biosensors—general 82<BR>(ii) Biosensors and FMD 82<BR>(f) Maintaining a state of preparedness 82<BR>(g) Integrating diagnosis to rapid response 83<BR>(h) General conclusions on diagnosis of other List A diseases 83<BR>(i) Recommendations 84<BR>References 84<BR>8 Vaccination 87<BR>(a) Introduction 87<BR>(b) Elimination of infectious diseases by vaccines 87<BR>(i) Experience of routine vaccination for FMD 88<BR>(ii) The immune responses to viral infections 90<BR>(iii) The immune response to viral vaccines 91<BR>(iv) The economics of routine vaccination 93<BR>(v) Key design features of vaccines 94<BR>(c) Improving routine vaccines for FMD 96<BR>(d) Emergency vaccination against FMD 97<BR>(i) The carrier state 97<BR>(ii) Are carrier animals infectious? 98<BR>(iii) Discriminating between vaccinated and infected animals 99<BR>(iv) Efficacy of emergency vaccines in an outbreak 100<BR>(v) The role of vaccine banks 101<BR>(vi) Exit strategies 102<BR>(e) Vaccines against other exotic viral diseases of livestock 102<BR>(i) High-risk diseases 102<BR>(ii) Medium-risk diseases 104<BR>(iii) Low-risk diseases 104<BR>(f) Recommendations 105<BR>References 105<BR>9 Dealing with an outbreak: control measures and relevant wider issues 111<BR>(a) Introduction and background 111<BR>(i) Ethics and welfare issues 111<BR>(ii) Environmental issues 112<BR>(iii) Human health considerations 113<BR>(iv) Resources 113<BR>(v) Permanent standstill periods for all livestock 113<BR>(vi) Increased levels of surveillance on farm 113<BR>(vii) Technical input to the control of disease 114<BR>(b) Key control measures that can be applied during an outbreak 115<BR>(i) Enhanced biosecurity 115<BR>(ii) Culling 116<BR>(iii) Emergency vaccination 118<BR>(iv) Special arrangements—zoos and rare breeds 121<BR>(v) Requirements at end of outbreak 122<BR>(c) Control of other diseases 122<BR>Contol measures 123<BR>(d) Contingency planning 123<BR>Development of the control policy component within the contingency plan 124<BR>(e) Recommendations 124<BR>References 125<BR>10 Research and development, education and training 131<BR>(a) Research and development 131<BR>(i) Introduction 131<BR>(ii) Animal disease research in Britain 131<BR>(iii) Current provision and issues 132<BR>(iv) Resources 135<BR>(b) Education and training 136<BR>(i) Farmers and livestock keepers 136<BR>(ii) Undergraduate veterinary education 136<BR>(iii) Continuing professional development 137<BR>References 139<BR>Annex A: Terms of reference 141<BR>Annex B: Conduct of the Inquiry 143<BR>Annex C: List of those who gave evidence 147<BR>Annex D: Glossary 157<BR>Figures<BR>2.1 Maps of livestock distributions in England 9<BR>2.2 Land use in the UK 10<BR>2.3 Value of UK livestock production (£ millions) in 1996 and 2000 10<BR>2.4 Analysis of UK livestock holdings by size and total area 11<BR>2.5 Numbers of livestock holdings, animals and average herd of flock size in the UK 11<BR>2.6 UK livestock numbers in 1967 and 2000 11<BR>2.7 Exports of livestock and livestock products from the UK (£ millions) 15<BR>3.1 The 15 List A diseases and their incidences in the UK 17<BR>3.2 Other notifiable diseases in the UK (excluding those of fish) 18<BR>3.3 Maximum virus excretion/secretion routes in cattle 20<BR>3.4 Most likely method of spread of FMD in each geographic area 21<BR>3.5 Airborne spread of the FMD virus during the 1967–68 epidemic 22<BR>3.6 Movement of FMD-infected animals before 23 February 2001, and locations of implicated<BR>markets, abattoirs and dealers 23<BR>4.1 Levels of ‘disease-free status’ for foot and mouth diseases (FMD) 41<BR>4.2 General conditions for regaining disease-free status after an outbreak of foot-and-mouth disease 41<BR>4.3 Conditions for regaining disease-free status after an outbreak of foot-and-mouth disease. 41<BR>5.1 The spread of Type O pan-Asia strain of FMD virus since 1990 44<BR>5.2 Probability of purchasing one or more Mycobacterium paratuberculosis infected cattle, by number<BR>and source of introduced cattle 54<BR>5.3 Probability of purchasing one or more cows persistently infected with bovine viral diarrhoea,<BR>by number and source of introduced cows 54<BR>6.1 Local conditions determine the impact of a control policy 59<BR>6.2 Development of virus in blood and breath relative to the appearance of clinical signs for a<BR>typical FMD infection in a single cow 59<BR>6.3 The development through time of the number of secondary infections generated from<BR>one infected farm 60<BR>6.4 Early and apparently harsh interventions can save animal lives in the long run 61<BR>6.5 R0 map from the 2001 FMD epidemic. 63<BR>6.6 Case histories of the use of models of infectious disease for understanding, planning and predicting 67<BR>6.7 Some uses of models in understanding disease 69<BR>7.1 Methods for virus detection used in human and veterinary medicine 76<BR>8.1 Examples of successful human and veterinary vaccines 89<BR>8.2 Estimated annual costs (£ millions) of routine FMD vaccination in the UK 94<BR>8.3 Exotic viral diseases that pose a threat to UK livestock 103<BR>9.1 The technical input to the decision-making process 115<BR>9.2 Criteria to be taken into account when considering emergency vaccination 120<BR>9.3 Biological properties of other List A viruses threatening the UK 126<BR>10.1 Average number of research publications per year on livestock diseases during 1991–2001 134<BR>10.2 Postgraduate qualifications in selected veterinary subjects, as at 31 December 2001 137</p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=2502/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
